BUSINESS

• Towa Resumes Packaging Operations at Fire-Hit Yamagata Facility
  July 17, 2025

• Nobelpharma’s Pediatric Sleep Aid Melatonin Wins Nod in China
  July 17, 2025

• Fire Breaks Out at Towa’s Yamagata Plant, Production Halted at One Building
  July 16, 2025

• JCR, Acumen Hook Up to Develop BBB-Penetrating Alzheimer’s Therapy
  July 16, 2025

• Otsuka Bags Autoimmune Antibody Drug from Swedish Biotech
  July 16, 2025

• Global Pharma Market Surges 9% to US$1.6 Trillion in 2024, Ozempic Overtakes Humira: IQVIA
  July 16, 2025

• Asahi Kasei Sharpens Acquisition Focus in Pharma Biz as Envarsus LOE Looms
  July 15, 2025

• MSD Seeks Japan Nod for RSV Antibody Clesrovimab
  July 15, 2025

• Takeda’s OX2R Agonist Makes Mark in PIII NT1 Trials, US Filing Planned in FY2025
  July 15, 2025

• FDA Rejects Capricor/Nippon Shinyaku’s DMD Cell Therapy, Seeking More Data
  July 15, 2025

• Eisai Launches Gout Drug Urece in China
  July 15, 2025

• Japan’s Feliqs to Relocate Headquarters to US, Launch PIb for ROP Drug
  July 15, 2025

• JWP-Led Holdings Firm Launched for Nichi-Iko, Kyowa, and Teva Takeda
  July 15, 2025

• Merck Japan Joins Hands with Kawasaki City Incubator to Support Startups
  July 15, 2025

• Taking on Solid Tumors - 8: Amgen Gains Early Lead with TCE Imdelltra, More Assets in the Pipeline
  July 14, 2025

• MSD Files for Japan Approval of Once-Daily HIV Combo Pill
  July 14, 2025

• Toho, Teijin, and Itochu to Jointly Build Regenerative Medicine Ecosystem
  July 14, 2025

• Solasia Invests in Sweden’s Isofol as Colorectal Cancer Trials Resume
  July 14, 2025

• All Three PPI Switch OTCs Approved following MHLW Panel OK
  July 14, 2025

• More Firms Signal Interest in Meiji-Daito Consortium to Revamp Generic Production
  July 14, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• …
• Next ›
• 最終 »